Gilead Sciences, Inc.
NasdaqGS:GILD
$ 62.32
+ $0.63 (1.02%)
$ 62.32
+ $0.63 (1.02%)
End-of-day quote: 10/03/2022

GILD - Gilead Sciences Stock Prediction 2025 - 2030

20 years of reliable Gilead Sciences stock forecast. The Wall Street analysts predict Outperform for GILD. See at a glance whether NasdaqGS:GILD will rise in the future.

$59.35
Forecast 2022
$66.01
Forecast 2025
$72.86
Forecast 2030
Neutral
TopGraphs Quality Ranking
Forecast 2022
$59.35
Forecast 2025
$66.01
Forecast 2030
$72.86
TopGraphs Quality Ranking
Neutral

Gilead Sciences Stock Forecast 2022

$71.00

In the last five quarters, Gilead Sciences's Price Target has fallen from $73.02 to $69.65 - tiny decrease of -4.62%. Nineteen analysts predict that Gilead Sciences's share price will increase slightly in the coming year, reaching 71.00. This would represent an increase of 1.94%.

13.93%
13.93

Highest Price Target $90.00

Average Price Target $71.00

Lowest Price Target $56.00

Gilead Sciences Stock Predictions 2025

Stock Forecast for the Price of an Gilead Sciences Share in Jan 2025.

In January 2025, analysts believe the stock price will be $63.92. An increase of 2.56% compared to the previous month's estimate.

Stock Forecast for the Price of an Gilead Sciences Share in Feb 2025.

In February 2025, analysts believe the stock price will be $64.11. An increase of 2.87% compared to the previous month's estimate.

Stock Forecast for the Price of an Gilead Sciences Share in Mar 2025.

In March 2025, analysts believe the stock price will be $64.30. An increase of 3.17% compared to the previous month's estimate.

Stock Forecast for the Price of an Gilead Sciences Share in Apr 2025.

In April 2025, analysts believe the stock price will be $64.49. An increase of 3.48% compared to the previous month's estimate.

Stock Forecast for the Price of an Gilead Sciences Share in May 2025.

In May 2025, analysts believe the stock price will be $64.68. An increase of 3.78% compared to the previous month's estimate.

Stock Forecast for the Price of an Gilead Sciences Share in Jun 2025.

In June 2025, analysts believe the stock price will be $64.87. An increase of 4.09% compared to the previous month's estimate.

Stock Forecast for the Price of an Gilead Sciences Share in Jul 2025.

In July 2025, analysts believe the stock price will be $65.06. An increase of 4.39% compared to the previous month's estimate.

Stock Forecast for the Price of an Gilead Sciences Share in Aug 2025.

In August 2025, analysts believe the stock price will be $65.25. An increase of 4.7% compared to the previous month's estimate.

Stock Forecast for the Price of an Gilead Sciences Share in Sep 2025.

In September 2025, analysts believe the stock price will be $65.44. An increase of 5.01% compared to the previous month's estimate.

Stock Forecast for the Price of an Gilead Sciences Share in Oct 2025.

In October 2025, analysts believe the stock price will be $65.63. An increase of 5.31% compared to the previous month's estimate.

Stock Forecast for the Price of an Gilead Sciences Share in Nov 2025.

In November 2025, analysts believe the stock price will be $65.82. An increase of 5.62% compared to the previous month's estimate.

Stock Forecast for the Price of an Gilead Sciences Share in Dec 2025.

In December 2025, analysts believe the stock price will be $66.01. An increase of 5.92% compared to the previous month's estimate.

Gilead Sciences Stock Prediction 2030

Stock Prediction for the Price of One Gilead Sciences Share in Jan 2030.

In Jan 2030 analysts predict a share price of $72.27. An increase of 15.97% compared to today's share price.

Stock Prediction for the Price of One Gilead Sciences Share in Feb 2030.

In Feb 2030 analysts predict a share price of $72.32. An increase of 16.05% compared to today's share price.

Stock Prediction for the Price of One Gilead Sciences Share in Mar 2030.

In Mar 2030 analysts predict a share price of $72.38. An increase of 16.14% compared to today's share price.

Stock Prediction for the Price of One Gilead Sciences Share in Apr 2030.

In Apr 2030 analysts predict a share price of $72.43. An increase of 16.22% compared to today's share price.

Stock Prediction for the Price of One Gilead Sciences Share in May 2030.

In May 2030 analysts predict a share price of $72.48. An increase of 16.31% compared to today's share price.

Stock Prediction for the Price of One Gilead Sciences Share in Jun 2030.

In Jun 2030 analysts predict a share price of $72.54. An increase of 16.4% compared to today's share price.

Stock Prediction for the Price of One Gilead Sciences Share in Jul 2030.

In Jul 2030 analysts predict a share price of $72.59. An increase of 16.48% compared to today's share price.

Stock Prediction for the Price of One Gilead Sciences Share in Aug 2030.

In Aug 2030 analysts predict a share price of $72.64. An increase of 16.57% compared to today's share price.

Stock Prediction for the Price of One Gilead Sciences Share in Sep 2030.

In Sep 2030 analysts predict a share price of $72.70. An increase of 16.65% compared to today's share price.

Stock Prediction for the Price of One Gilead Sciences Share in Oct 2030.

In Oct 2030 analysts predict a share price of $72.75. An increase of 16.74% compared to today's share price.

Stock Prediction for the Price of One Gilead Sciences Share in Nov 2030.

In Nov 2030 analysts predict a share price of $72.80. An increase of 16.82% compared to today's share price.

Stock Prediction for the Price of One Gilead Sciences Share in Dec 2030.

In Dec 2030 analysts predict a share price of $72.86. An increase of 16.91% compared to today's share price.

Company Info

P/E Ratio
9.1
Beta
0.33
Price-to-book Ratio
3.86
Market Cap
78.11B
TEV
101.117 B
LT Debt/Cap
0.06%
Dividend
$2.95
Div Yld
4.73%
Forecast 1Y
0.33%
Forecast 2Y
5.47%
Analyst Price Target
$69.65

About Gilead Sciences

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

Gilead Sciences Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y
P/E Ratio
9.1
Beta
0.33
Price-to-book Ratio
3.86
Market Cap
78.11B
TEV
101.117 B
LT Debt/Cap
0.06%
Dividend
$2.95
Div Yld
4.73%
Forecast 1Y
0.33%
Forecast 2Y
5.47%
Analyst Price Target
$69.65

Financials

Year Year 2020 2021
Rev. Revenue
24689.00 27305.00
GM % Gross Margin %
85.1 79.8
OI Operating Income
11217.00 11170.00
OM Operating Margin
45.43 40.91
NI Net Income
123.00 6225.00
EPS % Earnings Per Share %
7.09 7.28
Div. Dividends
2.72 2.84
PR % Payout Ratio %
38.36 39.01
Sha. Shares
1254 1254
OCF Operating Cash Flow
8168 11384
CS Cap Spending
-650 -650
FCF Free Cash Flow
7518 10734
FCFS Free Cash Flow Per Share
5.98 8.60

Gilead Sciences Analyst Ratings Frequently Asked Questions

Who are the analysts watching Gilead Sciences, Inc.?

The following analysts have recently covered Gilead Sciences:

Argus Research Company
Atlantic Equities LLP
Baird
Baptista Research
Barclays
BMO Capital Markets Equity Research
BofA Global Research
CFRA Equity Research
CGS-CIMB / CIMB Research
Citigroup Inc
Cowen and Company
Daiwa Securities Co. Ltd.
Day By Day
Evercore ISI
Goldman Sachs
J.P. Morgan
Jefferies LLC
Marktfeld
Maxim Group
Mizuho Securities USA LLC
Moody’s
Morgan Stanley
Morningstar Inc.
Needham & Company
Oppenheimer & Co. Inc.
Piper Sandler Companies
Raymond James & Associates
RBC Capital Markets
Redburn
Truist Securities
UBS Investment Bank
Wells Fargo Securities, LLC
Wolfe Research, LLC.
SVB Securities LLC
Cantor Fitzgerald & Co.
(This information refers to the last 90 days.)

Who are the sell-side analysts watching Gilead Sciences, Inc.?

The following sell-side analysts have recently covered Gilead Sciences:

Hellweg, Jasper
Chesney, Steven Kent
Skorney, Brian Peter
Majumdar, Ishan
Gould, Carter Lewis
Seigerman, Evan David
Meacham, Geoffrey Christopher
Glickman, Stewart
Seedhouse, Steven James
Bansal, Mohit
Van Buren, Tyler Martin
Nakagiri, Narumi
Raffat, Umer
Yee, Michael Jonathan
Paraskevopoulos, Michail
Okunewitch, Michael
Syed, Salim Qader
Harrison, Matthew Kelsey
Andersen, Karen
Stringer, Joseph Robert
Singh, Hartaj
Kim, Guyn
Davis, Luke
Baker, Simon P.
Karnauskas, Robyn Kay Shelton
Bristow, Colin Nigel
Richter, Salveen Jaswal
Risinger, David Reed
Gastaldy, Valérie
Brayer, Olivia Simone
Schott, Christopher Thomas
Anderson, Timothy Minton
Kumaar, Mohit
(This information refers to the last 90 days.)

© Copyright 2022 | TopGraphs™ | All Rights Reserved

To use TopGraphs™, you must accept our Terms and Conditions and Privacy Policy